CytoAgents Inc. completed the dose-limiting toxicity observation for the first cohort in a trial targeting CRS in blood cancer patients. The Safety Review Committee approved dose escalation for the ...

A drug’s therapeutic index is a ratio that doctors use when prescribing medications and determining dosage. It shows how much of a drug a person’s blood can contain before it becomes toxic.

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a ...

Heterogeneous escalation of radiotherapy dose guided by imaging in locally advanced non–small cell lung cancer (NSCLC) does not increase early toxicity, a new trial found. “Patients with ...

The infant died from a toxic dose of diphenhydramine - an antihistamine found in medications like Benadryl - which prosecutors say Villa gave her without medical approval. According to court ...

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis Quantum BioPharma Mon, May 12, 2025, 8:00 AM 2 ...

"A toxic dose can lead to serious symptoms including seizures, confusion, rapid heart rate, hallucinations, urinary retention, and ataxia." Compounding concerns is the fact that no one knows for ...

The dose limiting toxicity (DLT) dose level has not been identified in doses up to 250 mg/day. Systemic exposure increased with increased doses of NXP900, achieving clinically relevant ...

“We are very pleased to have completed dosing in these toxicity studies as this advances the Lucid-21-302 drug development program,” said Dr. Andrzej Chruscinski, Vice-President, Scientific ...

These studies were commissioned to provide data to support an IND application with the US FDA. "We are very pleased to have completed dosing in these toxicity studies as this advances the Lucid-21-302 ...